Altimmune's existence depends almost entirely on the outcome of the Phase 2 trial for pemvidutide in MASH. Learn why ALT ...

Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) has announced the release of its fourth-quarter and full-year 2024 financial ...

WEST CONSHOHOCKEN, PA—William John Sibold, the President and CEO of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), has sold shares of the company worth $531,020. The transaction involved the sale ...

It’s reportedly a split deal that pays the Wasserman client $1.35MM in the majors, with another $500K available via performance bonuses. Madrigal, 28 in March, has spent the past five seasons in ...

Investors often closely monitor such transactions for insights into executive sentiment and potential impacts on stock performance. Madrigal Pharmaceuticals specializes in pharmaceutical ...

Equities researchers at Leerink Partnrs reduced their FY2026 earnings per share estimates for shares of Madrigal Pharmaceuticals in a note issued to investors on Wednesday, February 5th. Leerink ...

The major league portion of the contract is worth $1.35 million, according to The Post’s Joel Sherman, and contains another $500,000 in performance bonuses. Madrigal, 27, spent the last three ...

After hours: February 14 at 6:27:32 PM EST Loading Chart for MDGL ...

The Newberry Consort used the Valentine’s Day weekend to present a concert which examined the many aspects of love. This ...